Posted 21 сентября 2020, 07:01
Published 21 сентября 2020, 07:01
Modified 24 декабря 2022, 22:38
Updated 24 декабря 2022, 22:38
He is confident that research into the determinants of vaccination decisions must continue.
- Limitations may apply to small groups with primary immunodeficiencies. At the same time, autoimmune, rheumatological and even oncological diseases will not be a contraindication", - said the allergist RT.
He noted that, first of all, one should focus on the instructions of the Ministry of Health after the third phase of the drug research.
Karaulov also stressed that the study of a new coronavirus is "an endless process", which is associated "with the improvement of diagnosis and treatment".
- It is no coincidence that our Ministry of Health has already issued eight temporary guidelines for the prevention, diagnosis and treatment of coronavirus infection. And around the world about 100 vaccines are being developed, - the expert specified.
Let us recall that earlier, the immunologist Vladislav Zhemchugov named diseases in which vaccination against covid is absolutely contraindicated. He pointed out that in the list of contraindications, diseases associated with the administration of immunosuppressive drugs, for example, oncological ones. Previously, the physician has already said that the restrictions before vaccination against COVID-19 are similar to those that are adhered to before the flu shot. He specified that vaccination is prohibited at temperatures above 37 degrees. Also, hard alcohol should not be consumed before the injection of the new COVID-19 vaccine.
Russian development - the world's first registered vaccine against coronavirus - meanwhile, continues to be tested on citizens. Voluntary vaccination, which President Vladimir Putin spoke about, is giving way to compulsory vaccination. At the same time, the wishes of the head of state are not taken into account. An example of this is the report of the Research Institute of Organization and Informatization of Healthcare "Measures of state support for persons associated with the treatment of COVID-19".